Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Leos Lekland in connection with the acquisition of Metro Lekeland
Mandate

Vinge advises Leos Lekland in connection with the acquisition of Metro Lekeland

February 10, 2011

Leos Lekland, which conducts six children’s activity centres in Sweden and is part of the KF Group, has acquired Metro Lekeland which owns five activity centres in Norway. In the future, the combined operations will be conducted under the trademark, Leos Lekland. The turnover for 2011 is anticipated to amount to approximately SEK 100 million excluding new establishments and any acquisitions.
Vinge’s team consisted of, among others, Johan Winnerblad, Alexandra Kempe, Johan Mattsson and Peter Alstergren.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026